Publications

Cost-effectiveness and benefit-cost analyses of promoting handwashing with soap: A systematic review.

ROSS, I; BATH, D; WELLS, J; DREIBELBIS, R; Ejemot-Nwadiaro, R; Esteves Mills, J; GRECO, G; PITT, C; CUMMING, O;

2026

PLoS medicine, (2026).23 4 10.1371/journal.pmed.1004982.

NIHR Evidence to Policy pathway to Immunisation in China: the EPIC Synopsis.

Jit, M; Yu, H; Lason, HJ; Sun, M; CHANTLER, T; Yang, J; LIU, Y; Hou, Z;

2026

Global Health Research (2026). 10.3310/gjmj0916.

The effect of tranexamic acid during childbirth on maternal mortality: an epidemiological modelling and cost-effectiveness study.

Anti-fibrinolytics Trialists Collaborators Obstetr,;

2026

The Lancet. Global health, (2026).14 4 10.1016/S2214-109X(25)00521-2.

Using secondary costing data to inform priority setting: a survey of current approaches for TB.

Nemzoff, C; Menzies, NA; BOZZANI, F; MCQUAID, F; WHITE, RG; SWEENEY, S;

2026

International Journal of Tuberculosis and Lung Disease, (2026).30 4 10.5588/ijtld.25.0262.

Economic burden of typhoid fever by antimicrobial resistance in India: a modelling study 2023.

MOGASALE, VV; John, J; Ray, A; Farooqui, HH; Mogasale, V; Hutubessy, R; Dhoubhadel, BG; EDMUNDS, WJ; CLARK, A; ABBAS, K;

2026

The Lancet Regional Health - Southeast Asia, (2026).47, 10.1016/j.lansea.2026.100748.

Early childhood intervention for children at risk of developmental disabilities and their caregivers in Rwanda: study protocol for the PDC/Baby Ubuntu cluster randomised trial.

SCHERER, N; Nemerimana, M; NANYUNJA, C; Kitema, GF; SADOO, S; Iradukunda, F; Munyuzangabo, M; LASSMAN, R; ROTENBERG, S; Bagahirwa, I; GREENLAND, K; Chen, S; CAREW, M; Davey, C; GRECO, G; BANKS, LM; Musendo, DJ; Uwinkindi, F; KUPER, H; WEBB, EL; Baganizi, E; TANN, CJ;

2026

Trials, (2026).27 1 10.1186/s13063-026-09613-7.

The potential global health impact and net monetary benefit of programmatic use of improved influenza vaccines: a mathematical modelling study.

GOODFELLOW, L; Soble, A; Malvolti, S; Lambach, P; Jit, M; EGGO, RM; PROCTER, SR;

2026

Vaccine, (2026).60 Sup S2 10.1016/j.vaccine.2026.128455.

Impact and cost-effectiveness of maternal vaccine and short and long-acting monoclonal antibodies against respiratory syncytial virus among children in Japan: A modeling study.

Kitamura, N; Kimura, T; Morino, S; Suzuki, M; Cook, AR; ABBAS, K;

2026

Vaccine: X, (2026).30, 10.1016/j.jvacx.2026.100805.

Partial pictures: what routine health data can and cannot tell us about the quality of maternal and neonatal health services in Tanzania.

Molenaar, J; Kikula, A; Julius, Z; HANSON, C; Van Olmen, J; Pembe, AB; Beňová, L;

2026

Health policy and planning, (2026).41 5 10.1093/heapol/czag030.

Cost-effectiveness of cancer interventions in Rwanda: literature review and expert elicitation for health benefits package design.

Nemzoff, C; Madriz-Montero, A; Mumukunde, I; Sindambiwe, JM V; De Valois Ndishimye, I; Uyisabye, V; Humuza, J; Baltussen, R; Hitimana, R; SWEENEY, S; Matutina Umuhoza, S; Vassall, A;

2026

BMJ public health, (2026).4 1 10.1136/bmjph-2025-003718.